LH vs VYNE · P/E 23, rev $13.95B vs rev $501.0K
Laboratory Corporation of America Holdings (LH) versus Vyne Therapeutics Inc (VYNE) — a side-by-side from cached financials, not a winner call.
Laboratory Corporation of America Holdings (LH) is a diagnostics & research company listed on US.
Vyne Therapeutics Inc (VYNE) is a biotechnology company listed on NASDAQ.
Latest reported LH revenue for 2025-12-31 was $13.95B. Net income was $876.5M. LH currently screens at market cap $21.07B and trailing P/E 22.8.
Latest reported VYNE revenue for 2024-12-31 was $501.0K. Net income was -$39.8M. Revenue was up 18.2% from 2023-12-31 to 2024-12-31. VYNE currently screens at market cap $21.1M.
LH currently screens at market cap $21.07B and trailing P/E 22.8. VYNE currently screens at market cap $21.1M.
Not investment advice. Open the LH and VYNE stock pages for the full models.
Not investment advice.